| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.1M | +0.7% | +605.4% |
| R&D Expense | $3.4M | -0.0% | -68.6% |
| SG&A Expense | $16.9M | -18.5% | +4.5% |
| Operating Income | $4.1M | +105.8% | +115.2% |
| Pre-tax Income | -$977K | -101.3% | +97.1% |
| Income Tax | -$433K | -119.7% | — |
| Net Income | -$544K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.4M | +14.1% | +0.7% |
| Accounts Receivable | $16.8M | -7.8% | +116.2% |
| Inventory | $1.4M | +23.4% | — |
| Current Assets | $225.1M | -0.5% | +126.4% |
| Total Assets | $270.1M | +5.4% | +41.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.1M | — | — |
| Capital Expenditures | $866K | — | — |
| Investing Cash Flow | $17.9M | — | — |
| Financing Cash Flow | $9.5M | — | — |
| Free Cash Flow | -$8.0M | — | — |
| -100.7% |
| +98.4% |
| EPS (Basic) | -$0.01 | -100.8% | +98.6% |
| EPS (Diluted) | -$0.01 | -100.8% | +98.6% |
| $26.1M |
| -9.4% |
| -24.3% |
| Long-term Debt | $61.3M | +1.0% | +4.1% |
| Total Liabilities | $137.0M | -1.5% | +12.5% |
| Stockholders' Equity | $133.2M | +13.6% | +90.9% |